Cointime

Element Biosciences

company

About

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.

Highlights

Total Funding Amount
$401M
Funding Rounds
4
Investors
12
Acquisition
1
Employee Profiles
11

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology,Genetics,Health Diagnostics,Life Science
Founded date
Jul 7, 2017
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Element Biosciences, Inc.

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible.
Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$401M
Element Biosciences has raised a total of $401M in funding over 2 rounds. Their latest funding was raised on Jun 29, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2021 Series C $276M 10 Venrock — Detail
Jun 26, 2020 Series B $30M 2 — — Detail
Jan 9, 2020 Series B $80M 4 — — Detail
Jun 18, 2019 Series A $15M 2 Foresite Capital
Venrock 		— Detail

Investors

Number of Lead Investors
Number of Investors
3
12
Element Biosciences is funded by 12 investors. Venrock and Counterpoint Global are the most recent investors.
Investor Name Lead Investor Funding Round
Venrock Yes Series C
Counterpoint Global — Series C
Fidelity Management and Research Company — Series C
Foresite Capital — Series C
Janus Henderson Investors — Series C
JS Capital Management — Series C
Logos Capital — Series C
Meritech Capital Partners — Series C
RA Capital Management — Series C
T. Rowe Price — Series C
Show More

Employee Profiles

Number of Employee Profiles
11
Element Biosciences has 11 current employee profiles, including Board member Jim Tananbaum
Jim Tananbaum
Board member
Bryan Roberts
Board member
John Stuelpnagel
Board member
Molly He
Executive
Michael Previte
Executive
Show More

Acquisition

Element Biosciences has acquired 1 organizations. Their most recent acquisition was Loop Genomics on Feb 8, 2022. They acquired Loop Genomics for 0.

Date Company Name
Industry Acquisition Type Price
Feb 8, 2022 Loop Genomics
Biotechnology acquisition — Detail
Cointime
Content
Company